Evaluating the Addition of Bevacizumab to Endocrine Therapy as First-Line Treatment for Hormone Receptor-Positive Metastatic Breast Cancer: a Pooled Analysis from the LEA (GEICAM/2006-11_GBG51) and CALGB 40503 (Alliance) Trials
For patients recovering from an injury, dealing with chronic joint pain, or looking to improve flexibility, TB 500 peptide therapy may be a great option
Numerous studies utilizing adenoviral transduction of FAK-related non-kinase (FRNK), an endogenous dominant-negative inhibitor of the FAK FAT domain, showed displacement of FAK from focal adhesions, leading to increased cell rounding, detachment, and apoptosis 18,19
Orders placed and paid before 5:00 PM EST ship the same business day via Canada Post Xpresspost with full tracking
Frequently Asked Questions What is GHK-Cu studied for in research
The protective effect of naringenin against ovalbumin-induced allergic rhinitis in rats